Skip to content

High-intensity Interval Training in Patients With COPD: a Fidelity and Tolerability Study

High-intensity Interval Training in Patients With COPD: a Fidelity and Tolerability Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05273684
Acronym
COPDEX-HIIT
Enrollment
12
Registered
2022-03-10
Start date
2021-11-01
Completion date
2022-07-01
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD

Keywords

HIIT, COPD

Brief summary

Although high-intensity training (HIIT) is widely used in the rehabilitation of patients with chronic obstructive pulmonary disease (COPD), the optimal duration of intervals in terms of patient tolerability and fidelity is unknown.Thus, we will examine the fidelity and tolerability of the two most commonly used HIIT protocols, the classical so-called 4x4min vs. 10x1min in patients with moderate to severe COPD.

Detailed description

12 patients with severe to moderate COPD will be included in the study, where two different HIIT interventions will be compared with regards to fidelity and tolerability. Baseline measurements will be performed to assess fitness and cardiopulmonary health status for the included patients. The baseline measurements include a medical health interview and examination (blood pressure, heart rate, ECG), a maximal oxygen consumption (VO2max) test, lung function testing (dynamic spirometry, whole body plethysmography, diffusing capacity), and an assessment of body composition. The following two visits consist of two different HIIT protocols. Each training session is evaluated by Borg Scale (5) and the Likert Scale (6), as well as time spent in with a heart rate above 85% of maximum. Each HIIT session is separated by at least a 3-day wash-out period.

Interventions

OTHERHigh intensity interval training

Participants will undergo 4x4 and 1x10 minutes of interval training on two separate days.

Sponsors

Rigshospitalet, Denmark
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Men and women * 18-80 years * Moderate to severe COPD(GOLD stage II to III)

Exclusion criteria

* Known ischaemic heart disease * Known heart failure * Previous or current coronavirus disease 2019 (COVID-19) * Dementia or other severe neurological disease * Known vascular * Symptoms of disease within 2 weeks prior to the study * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Exercise feasibility: Relative dose intensity (RDI) of exercise1 weekRDI (%) of exercise, defined as prescribed exercise dose / performed exercise dose x 100 Evaluated with a Red-Amber-Green system: * Green: If ≥85% of the training is completed * Amber: If 50-85% of the training is completed * Red: If ≤ 50% of the training is completed
Exercise feasibility: Exercise sessions requiring dose modifications1 weekIncidence of exercise sessions requiring dose modifications, defined as any deviation from the prescribed exercise.
Exercise tolerability: Subjective rating of the exercise session1 weekTolerability is measured with a 10-point Likert scale, where the participants evaluate the two HIIT protocols. They will anser two quesitens: 1. How tolerable was todays traning? 2. How much did you enjoy todays training? Where 1 means not at all, and 10 means alot. The Likert scale is scored as: Red: 1-2 Amber: 3-4 Green: +5
Exercise feasibility: Exercise sessions attendance rate1 weekExercise sessions attendance rate (%), defined as number of attended exercise sessions / number of prescribed exercise sessions x 100

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 9, 2026